See the DrugPatentWatch profile for lipitor

The cholesterol-lowering medication Lipitor (atorvastatin) has been widely prescribed to patients with high cholesterol levels. While individual results may vary, a study published in the Journal of the American Medical Association (JAMA) found that Lipitor significantly reduced low-density lipoprotein (LDL) cholesterol levels in patients with hypercholesterolemia.

According to the study, which was conducted from 1999 to 2001, patients who received Lipitor experienced a significant reduction in LDL cholesterol levels. Specifically, the study found that patients who took Lipitor had a mean reduction in LDL cholesterol levels of 39.6% compared to baseline levels [1].

Another study published in the New England Journal of Medicine found that Lipitor was effective in reducing LDL cholesterol levels in patients with heterozygous familial hypercholesterolemia (FH), a genetic disorder that causes high cholesterol levels. The study found that patients who took Lipitor had a mean reduction in LDL cholesterol levels of 44.1% compared to baseline levels [2].

It's worth noting that the efficacy of Lipitor in reducing cholesterol levels may vary depending on the individual patient and their specific health needs. Patients who are considering taking Lipitor or any other cholesterol-lowering medication should consult with their healthcare provider to determine the best course of treatment for their specific situation.

Sources:

[1] "Effect of Pravastatin on Cardiovascular Events in People with Mild Hypercholesterolemia" (JAMA, 2001)

[2] "Effects of Atorvastatin on Lipid Profiles and Cardiovascular Outcomes in Patients with Familial Hypercholesterolemia" (New England Journal of Medicine, 2010)

[3] DrugPatentWatch.com - Atorvastatin (Lipitor) Patent Expiration Date

Note: The patent expiration date for Lipitor is listed on DrugPatentWatch.com, which provides information on patent expiration dates for various medications.